Victory Capital Management Inc. Has $795,000 Stock Position in Viemed Healthcare, Inc. (NASDAQ:VMD)

Victory Capital Management Inc. grew its position in Viemed Healthcare, Inc. (NASDAQ:VMD) by 748.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 108,497 shares of the company’s stock after purchasing an additional 95,706 shares during the period. Victory Capital Management Inc. owned about 0.28% of Viemed Healthcare worth $795,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in shares of Viemed Healthcare by 53.0% during the 1st quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock valued at $16,803,000 after purchasing an additional 617,009 shares in the last quarter. Apis Capital Advisors LLC raised its holdings in Viemed Healthcare by 193.0% during the second quarter. Apis Capital Advisors LLC now owns 234,400 shares of the company’s stock valued at $1,535,000 after buying an additional 154,400 shares in the last quarter. Price T Rowe Associates Inc. MD bought a new position in Viemed Healthcare during the first quarter valued at about $97,000. Paradigm Capital Management Inc. NY lifted its position in shares of Viemed Healthcare by 25.0% in the second quarter. Paradigm Capital Management Inc. NY now owns 400,000 shares of the company’s stock worth $2,620,000 after buying an additional 80,000 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in shares of Viemed Healthcare by 11.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 95,388 shares of the company’s stock worth $625,000 after acquiring an additional 9,792 shares in the last quarter. 74.24% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Randy E. Dobbs sold 36,261 shares of the company’s stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the completion of the transaction, the director now directly owns 107,706 shares in the company, valued at $999,511.68. The trade was a 25.19 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Nitin Kaushal sold 5,995 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $8.58, for a total value of $51,437.10. Following the completion of the sale, the director now directly owns 126,843 shares of the company’s stock, valued at $1,088,312.94. This represents a 4.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 72,256 shares of company stock worth $674,739 in the last quarter. 20.00% of the stock is currently owned by company insiders.

Viemed Healthcare Stock Performance

Shares of NASDAQ VMD opened at $8.56 on Friday. The business’s 50-day simple moving average is $8.56 and its 200-day simple moving average is $7.59. Viemed Healthcare, Inc. has a 52 week low of $6.21 and a 52 week high of $10.44. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The firm has a market cap of $333.30 million, a price-to-earnings ratio of 31.70 and a beta of 1.43.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The company had revenue of $58.00 million for the quarter.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.